UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.510-519

2019

Volltextzugriff (PDF)

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

Alzheimer's research & therapy, 2012-10, Vol.4 (5), p.43-43, Article 43

2012

Volltextzugriff (PDF)

White matter alterations in early-stage Alzheimer's disease: A tract-specific study

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.576-587

2019

Volltextzugriff (PDF)

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease

Alzheimer's research & therapy, 2021-06, Vol.13 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea

Alzheimer's research & therapy, 2024-04, Vol.16 (1), p.92-11, Article 92

2024

Volltextzugriff (PDF)

Donanemab in Early Alzheimer’s Disease

The New England journal of medicine, 2021-05, Vol.384 (18), p.1691-1704

2021

Volltextzugriff (PDF)

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

Alzheimer's research & therapy, 2020-08, Vol.12 (1), p.93-93, Article 93

2020

Volltextzugriff (PDF)

Communicating mild cognitive impairment diagnoses with and without amyloid imaging

Alzheimer's research & therapy, 2017-05, Vol.9 (1), p.35-35, Article 35

2017

Volltextzugriff (PDF)

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-08, Vol.330 (6), p.512

2023

Volltextzugriff (PDF)

Virtual reality cognitive intervention for heart failure: CORE study protocol

Alzheimer's & dementia : translational research & clinical interventions, 2022, Vol.8 (1), p.e12230-n/a

2022

Volltextzugriff (PDF)

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2016, Vol.2 (1), p.113-122

2016

Volltextzugriff (PDF)

Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2019-12, Vol.11 (1), p.784-786

2019

Volltextzugriff (PDF)

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI

Human brain mapping, 2010-05, Vol.31 (5), p.786-797

2010

Volltextzugriff (PDF)

Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy

Journal of Alzheimer's disease, 2020-01, Vol.73 (4), p.1305-1311

2020

Volltextzugriff (PDF)

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & dementia : translational research & clinical interventions, 2021, Vol.7 (1), p.e12168-n/a

2021

Volltextzugriff (PDF)

Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis

JAMA neurology, 2018-03, Vol.75 (3), p.328

2018

Volltextzugriff (PDF)

Head injury is associated with tau deposition on PET in MCI and AD patients

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2021, Vol.13 (1), p.e12230-n/a

2021

Volltextzugriff (PDF)

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway

Nature neuroscience, 2024-07, Vol.27 (7), p.1236-1252

2024

Volltextzugriff (PDF)

TAF15 amyloid filaments in frontotemporal lobar degeneration

Nature (London), 2024-01, Vol.625 (7994), p.345-351

2024

Volltextzugriff (PDF)

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [ 18 F]Flortaucipir PET

Acta neuropathologica communications, 2018-10, Vol.6 (1), p.114-114, Article 114

2018

Volltextzugriff (PDF)

Social Networks and Cognitive Reserve: Network Structure Moderates the Association Between Amygdalar Volume and Cognitive Outcomes

The journals of gerontology. Series B, Psychological sciences and social sciences, 2022-08, Vol.77 (8), p.1490-1500

2022

Volltextzugriff (PDF)

Atypical Alzheimer Disease Variants

Continuum (Minneapolis, Minn.), 2022-06, Vol.28 (3), p.676-701

2022

Volltextzugriff (PDF)

The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests

Journal of Alzheimer's disease, 2016-01, Vol.51 (4), p.1145-1155

2016

Volltextzugriff (PDF)

Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease

Alzheimer's & dementia, 2024-09

2024

Volltextzugriff (PDF)

Neuroimaging in Dementia

Continuum (Minneapolis, Minn.), 2023-02, Vol.29 (1), p.219-254

2023

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

White matter alterations in early-stage Alzheimer's disease: A tract-specific study

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease

Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea

Donanemab in Early Alzheimer’s Disease

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

Communicating mild cognitive impairment diagnoses with and without amyloid imaging

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Virtual reality cognitive intervention for heart failure: CORE study protocol

Novel verbal fluency scores and structural brain imaging for prediction of cognitive outcome in mild cognitive impairment

Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider

3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI

Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy

Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis

Head injury is associated with tau deposition on PET in MCI and AD patients

Apolipoprotein E in Alzheimer's disease trajectories and the next-generation clinical care pathway

TAF15 amyloid filaments in frontotemporal lobar degeneration

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [ 18 F]Flortaucipir PET

Social Networks and Cognitive Reserve: Network Structure Moderates the Association Between Amygdalar Volume and Cognitive Outcomes

Atypical Alzheimer Disease Variants

The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests

Integrating amyloid imaging and genetics for early risk stratification of Alzheimer's disease

Neuroimaging in Dementia

Aktive Filter

Suchergebnisse filtern